Exparel and Education to Avoid Opioids After Carpal Tunnel Release
Carpal Tunnel Syndrome
About this trial
This is an interventional supportive care trial for Carpal Tunnel Syndrome focused on measuring hand, exparel, opioid crisis
Eligibility Criteria
Inclusion Criteria:
- carpal tunnel syndrome diagnosed either by physical exam or EMG
- age >18.
Exclusion Criteria:
- allergy to bupivacaine
- pre-operative opioid usage within the last six months
- patients allergic to Percocet or acetaminophen
- patients taking tricyclic antidepressants (interaction with bupivacaine)
- vulnerable populations (prisoners or pregnant women)
Sites / Locations
- Orthopedic Associates of Southwest OhioRecruiting
- Orthopedic Associates of Southwest OhioRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Control Group; Bupivacaine + opioids
Experimental Group: Exparel, no opioids
This is the "standard of care" arm. This group will receive pre-operative opioid education and "standard of care", which consists of an injection of 10cc bupivacaine (plus ~1cc epinephrine and bicarbonate) into the carpal tunnel and overlying skin pre-operatively, and a post operative prescription for opioids (oxycodone/acetaminophen 5/325). Pain scores and medication usage will be tracked for three days post operatively to assess the validity and efficacy of differing pain management strategies.
This group will receive pre-operative opioid education, Exparel injection (liposomal bupivacaine, with bupivacaine, epinephrine and bicarbonate), and would not receive a prescription for opioids. This injection will be administered as 10cc injected in the operative field, consisting of ~5cc of Exparel (liposomal bupivacaine), ~5cc of bupivacaine, and ~1cc epinephrine. Pain scores and medication usage will be tracked for three days post operatively to assess the validity and efficacy of differing pain management strategies.